Fortis Healthcare Limited

Kvartální The Relevant disclosure is attached FY2027 · Q1BSEPDF 6. srp 2026 před 3 měs. Výroční Annual Report FY2026 FY2026BSEPDF 17. čvc 2026 před 3 měs. Výroční Financial results for the Quarter and Year ended March 31, 2026 FY2026BSEPDF 22. kvě 2026 před 5 měs. Kvartální The relevant disclosure is attached FY2026 · Q3BSEPDF 13. úno 2026 před 8 měs. Kvartální The relevant disclosure is attached FY2026 · Q2BSEPDF 11. lis 2025 před 1 r. Kvartální Financial Results for Quarter Ended June 30, 2025 is attached. FY2026 · Q1BSEPDF 6. srp 2025 před 1 r. Výroční Annual Report FY2025 FY2025BSEPDF 14. čvc 2025 před 1 r. Výroční The relevant disclosure is attached with respect to Audited Financial Results for the year ended March 31, 2025. FY2025BSEPDF 20. kvě 2025 před 1 r. Kvartální Relevant disclosure with respect to Financial Results is attached FY2025 · Q3BSEPDF 7. úno 2025 před 2 r. Kvartální As per attached FY2025 · Q2BSEPDF 8. lis 2024 před 2 r. Kvartální The relevant Disclosure is attached FY2025 · Q1BSEPDF 6. srp 2024 před 2 r. Výroční Annual Report FY2024 FY2024BSEPDF 11. čvc 2024 před 2 r. Výroční Outcome of Board Meeting May 23, 2024, please find the detailed disclosure enclosed. FY2024BSEPDF 23. kvě 2024 před 2 r. Kvartální Un-audited Financial Results for the quarter ended December 31, 2023 FY2024 · Q3BSEPDF 7. úno 2024 před 3 r. Kvartální The Board of Director of the Company in their meeting held on November 10, 2023 inter-alia considered and approved the standalone and consolidated unaudited financial results for the quarter .... FY2024 · Q2BSEPDF 10. lis 2023 před 3 r. Kvartální Pursuant to Regulation 30 of SEBI LODR, please find enclosed un-audited standalone and consolidated financial results for the quarter ended June 30, 2023 FY2024 · Q1BSEPDF 4. srp 2023 před 3 r. Výroční Annual Report FY2023 FY2023BSEPDF 8. čvc 2023 před 3 r. Výroční This is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 23, 2023, inter-alia, has: a)Considered and approved the standalone and consolidated .... FY2023BSEPDF 23. kvě 2023 před 3 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2023 · Q3BSEPDF 10. úno 2023 před 4 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2023 · Q2BSEPDF 11. lis 2022 před 4 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2023 · Q1BSEPDF 5. srp 2022 před 4 r. Výroční Annual Report FY2023 FY2023BSEPDF 8. čvc 2022 před 4 r. Výroční Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2022BSEPDF 25. kvě 2022 před 4 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2022 · Q3BSEPDF 11. úno 2022 před 5 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2022 · Q2BSEPDF 12. lis 2021 před 5 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2022 · Q1BSEPDF 13. srp 2021 před 5 r. Výroční Annual Report FY2022 FY2022BSEPDF 7. čvc 2021 před 5 r. Výroční Please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the .... FY2021BSEPDF 29. kvě 2021 před 5 r. Kvartální The detailed disclosures as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed. FY2021 · Q3BSEPDF 5. úno 2021 před 6 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2021 · Q2BSEPDF 12. lis 2020 před 6 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2021 · Q1BSEPDF 14. srp 2020 před 6 r. Výroční Annual Report FY2021 FY2021BSEPDF 7. srp 2020 před 6 r. Výroční Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2020BSEPDF 17. čvn 2020 před 6 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2020 · Q3BSEPDF 14. úno 2020 před 7 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2020 · Q2BSEPDF 6. lis 2019 před 7 r. Kvartální This is with reference to our letter ref. no. FHL/SEC / 2019-20, dated August 6, 2019, captioned 'Outcome of the Board Meeting', we would like to submit that there was an inadvertent typographical .... FY2020 · Q1BSEPDF 7. srp 2019 před 7 r. Výroční Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2019BSEPDF 24. kvě 2019 před 7 r. Kvartální Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company .... FY2019 · Q3BSEPDF 13. úno 2019 před 8 r. Kvartální This is to inform you that the Board of Directors of the Company at its meeting held on November 5, 2018, inter-alia, considered and approved Un-Audited Financial Results and Limited Review .... FY2019 · Q2BSEPDF 5. lis 2018 před 8 r. Kvartální This is to inform you that the Board of Directors of the Company at its meeting held on August 14, 2018, inter-alia, considered and approved the following: - 1. Un-Audited Financial .... FY2019 · Q1BSEPDF 14. srp 2018 před 8 r. Výroční The Board of Directors of the Fortis Healthcare Limited (the 'Company') at its meeting, inter alia, considered and noted the Un-Audited Financial Results of the Company for the year ended .... FY2018BSEPDF 27. čvn 2018 před 8 r. Kvartální This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the Un-Audited Financial Results and Limited Review Report .... FY2018 · Q3BSEPDF 1. bře 2018 před 9 r. Kvartální This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the following: 1.Un-Audited Financial Results and Limited .... FY2018 · Q1BSEPDF 4. srp 2017 před 9 r. Výroční This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the Audited Consolidated and Standalone Financial Results .... FY2017BSEPDF 30. kvě 2017 před 9 r. Kvartální With reference to the earlier letter dated February 14, 2017 regarding Financial Result for the December 31, 2016, Fortis Healthcare Ltd has now informed BSE that there was an inadvertent .... FY2017 · Q3BSEPDF 14. úno 2017 před 10 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended December 31, 2016: The Unaudited Standalone results for the Quarter ended December 31, 2016 The .... FY2017 · Q3BSEPDF 14. úno 2017 před 10 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended September 30, 2016: The Unaudited Standalone results for the Quarter ended September 30, 2016 .... FY2017 · Q2BSEPDF 10. lis 2016 před 10 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended June 30, 2016: The Unaudited Standalone results for the Quarter ended June 30, 2016 The Company .... FY2017 · Q1BSEPDF 4. srp 2016 před 10 r. Výroční Fortis Healthcare Ltd has announced the following results for the quarter & year ended March 31, 2016: The Audited Standalone results for the Quarter ended March 31, 2016 The .... FY2016BSEPDF 26. kvě 2016 před 10 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended December 31, 2015 The Unaudited Standalone results for the Quarter ended December 31, 2015: The .... FY2016 · Q3BSEPDF 4. úno 2016 před 11 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended September 30, 2015: The Unaudited Standalone results for the Quarter ended September 30, 2015 .... FY2016 · Q2BSEPDF 4. lis 2015 před 11 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended June 30, 2015 : The Un-Audited Standalone results for the Quarter ended June 30, 2015: The .... FY2016 · Q1BSEPDF 6. srp 2015 před 11 r. Výroční Fortis Healthcare Ltd has announced the following results for the quarter & year ended March 31, 2015: The Standalone Results are as follows: The Audited results for the .... FY2015BSEPDF 28. kvě 2015 před 11 r. Kvartální Fortis Healthcare Ltd has announced the following results for the quarter ended December 31, 2014: The Unaudited Standalone results for the Quarter ended December 31, 2014 The .... FY2015 · Q3BSEPDF 13. úno 2015 před 12 r.